Carlsmed, Inc.
CARL
$11.95
-$0.41-3.32%
NASDAQ
| 06/30/2025 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Net Income | -18.10% | -15.24% | |||
| Total Depreciation and Amortization | 52.50% | -12.50% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 109.39% | -13.02% | |||
| Change in Net Operating Assets | 41.91% | 78.93% | |||
| Cash from Operations | 13.65% | 15.42% | |||
| Capital Expenditure | -293.98% | 66.00% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -122.58% | -- | |||
| Cash from Investing | -182.35% | 66.00% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -77.18% | -8.33% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -100.00% | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -519.57% | 200.00% | |||
| Cash from Financing | -119.20% | -84.08% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -401.18% | -100.51% | |||